Itolizumab
categoriaProducto: Commercials
modalidad: Antibodies
producidoPor: CIM
MONOCLONAL ANTIBODY anti-CD6
nombreComercial: CIMAReg®
formaFarmaceutica: Solution for injection. IV.
propiedadesFarmacologicas: NP
indicacionesTerapeuticas: Indicated for the treatment of adult patients confirmed with SARS-CoV2, who present moderate disease with high risk of aggravation, serious or critical. Patients must be hospitalized in the conventional ward or in intensive care units and have a suspected cytokine release syndrome.
aprobacionesEspecialesComercializacion: Use in emergency
Frequent Questions
How can I access the therapeutic vaccines against lung cancer?
Cuba has 2 therapeutic vaccines for advanced lung cancer:
CIMAvax EGF ® and VAXIRA ® (racotumomab). Both therapeutic vaccines have sanitary registration in the indication of stage III and IV advanced non-small cell lung cancer (NSCLC), after the first line of chemotherapy. The main clinical benefit of these vaccines has been shown to be increased survival and improved quality of life, as well as a broad safety profile.
How to acquire the vaccines?
Foreigners should contact the Cuban Medical Services who will evaluate each case as part of a comprehensive patient care program, with commercial value.
-Cuban Medical Services. Web page:
www.smcsalud.cu.; E-mail: smc@smcsalud.cu
Phone: (537) 209-0977 Fax: (537) 203-1590.
You can also make your request for care expressing the reason for your request, a medical summary and personal data directly to:
International Clinic of the Hermanos Ameijeiras Hospital.
Calle San Lázaro # 701 esq. to Belascoaín, Havana Center, Havana, C.P: 10400, Cuba.
Telephone: (537) 8761029, (537) 8761030, (537) 8761683. Email: turismomedico@hha.sld.cu
International Health Center
La Pradera Calle 15 between 222 A and 234, Siboney neighborhood, Playa Municipality, Havana, Cuba
Telephone: (+537) 273 7467 Ext. 403 (+537) 2737202. Email: comercia@cislapradera.cu